Virginia medical technology developer K2M announced on Wednesday that it will raise $40 million from stock sales, eight months after its $132 million IPO. The Leesburg-based company has developed ways of treating spinal diseases with devices for minimally invasive surgery for about a decade. The company posted a revenue of nearly $158 million, a loss of a little less than $38 million in the last fiscal year.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
